C07C 235/26
The carbon skeleton being saturated and containing rings
Official title: the carbon skeleton being saturated and containing rings
C07C235/26 (The carbon skeleton being saturated and containing rings) appears on 30 US grants and 25 published applications in this corpus.
Search patents in C07C- Granted patents
- 30
- Published applications
- 25
- Assignees
- 26
- Inventors
- 121
- Latest grant
- 7 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1990 | 1 | 0 |
| 1991 | 2 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 2 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 1 |
| 2002 | 1 | 2 |
| 2003 | 1 | 1 |
| 2004 | 1 | 2 |
| 2005 | 0 | 1 |
| 2006 | 0 | 1 |
| 2007 | 2 | 0 |
| 2008 | 1 | 3 |
| 2009 | 1 | 0 |
| 2010 | 1 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 1 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 1 | 3 |
| 2020 | 2 | 1 |
| 2021 | 0 | 1 |
| 2022 | 2 | 3 |
| 2023 | 1 | 1 |
| 2024 | 1 | 1 |
| 2025 | 2 | 0 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for treatment of platinum-based chemotherapeutic resistant tumors7 Apr 2026US 12,595,227 B2The George Washington University
- Prostaglandin EP4 receptor antagonist compounds19 Aug 2025US 12,391,641 B2Nxera Pharma UK Limitied
- Alcohol derivatives as Kv7 potassium channel openers25 Mar 2025US 12,258,305 B2H. Lundbeck A.S.
- Immunoregulatory agents19 Mar 2024US 11,932,601 B2Flexus Biosciences, Inc.
- Alcohol derivatives as KV7 potassium channel openers10 Jan 2023US 11,548,849 B2H. Lundbeck A.S.
- Prostaglandin ep4 receptor antagonist compounds15 Jan 2026US 2026/0015314 A1
- Alcohol derivatives as kv7 potassium channel openers3 Oct 2024US 2024/0327336 A1H. Lundbeck A.S.
- Compositions and methods for treatment of platinum-based chemotherapeutic resistant tumors12 Jan 2023US 2023/0012172 A1The George Washington University
- Prostaglandin ep4 receptor antagonist compounds29 Dec 2022US 2022/0411364 A1Nxera Pharma UK Limitied
- Alcohol derivatives as kv7 potassium channel openers1 Dec 2022US 2022/0380300 A1H. Lundbeck A.S.
Most cited
By later US patents
- Compounds and compositions for delivering active agents184US 5,643,957 AEmisphere Technologies, Inc. · 1997
- Compounds and compositions for delivering active agents67US 6,100,298 AEmisphere Technologies, Inc. · 2000
- Compounds and compositions for delivering active agents49US 5,955,503 AEmisphere Technologies, Inc. · 1999
- TRPV1 agonists, formulations containing them and uses thereof24US 7,429,673 B2Indena S. P. A. · 2008
- Substituted hydrindanes for the treatment of angiogenesis-dependent diseases18US 5,464,866 AAlcon Laboratories, Inc. · 1995